paxilline has been researched along with pentylenetetrazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barth, AL; Benedetti, BL; Sheehan, JJ | 1 |
| Ahmad-Molaei, L; Motamedi, F; Naderi, N; Shirazi-zand, Z | 1 |
2 other study(ies) available for paxilline and pentylenetetrazole
| Article | Year |
|---|---|
Anticonvulsant effects of the BK-channel antagonist paxilline.
Topics: Analysis of Variance; Animals; Animals, Newborn; Cell Count; Disease Models, Animal; Dose-Response Relationship, Drug; Electroencephalography; Hippocampus; Indoles; Mice; Mice, Inbred C57BL; Neocortex; Pentylenetetrazole; Picrotoxin; Potassium Channel Blockers; Proto-Oncogene Proteins c-fos; Psychomotor Performance; Seizures; Time Factors | 2009 |
The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice.
Topics: Analysis of Variance; Animals; Anticonvulsants; Cannabidiol; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Indoles; Injections, Intraventricular; Large-Conductance Calcium-Activated Potassium Channels; Male; Mice; Pentylenetetrazole; Potassium Channel Blockers; Seizures | 2013 |